Blood glucose equipment control method, system and device, storage medium and program
A technology for equipment control and blood sugar, which is applied in the field of biomedical engineering, can solve the problems of insufficient efficiency, convenience, and little difference in basic functions, etc., and achieve the effects of effective control of diabetes, efficient treatment of high blood sugar, and improvement of quality of life
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0054] A design method for intelligent real-time drug administration to control hyperglycemia, including the following four steps:
[0055] 1) Enter the transmission chip and connect the device;
[0056] 2) In the blood glucose reference interface of the transmission chip, a normal blood glucose concentration range (3.1-6.9mmol / L) is set, and any blood glucose value within this range is considered normal;
[0057] 3) Receive the data from the biosensor at all times and compare it with the blood glucose reference (standard blood glucose concentration) of the transmission chip. When the client shows that the blood glucose level is higher than 6.9mmol / L, the transmission chip will issue a command to the biosensor, and the biosensor will control the release of hypoglycemic drugs (such as insulin, metformin, etc.);
[0058] 4) The biosensor releases hypoglycemic drugs (such as insulin, metformin, etc.) to continue to regulate blood sugar, and the transmission chip receives data fr...
Embodiment 2
[0060] 1) The biosensor is in direct contact with the skin to detect the concentration of glucose in the surface capillaries connected to the skin;
[0061] 2) The detected data will be displayed on the biosensor display screen in the form of numbers, and displayed on the transmission chip in the form of graphs;
[0062] 3) At the same time, the data detected at this time is transmitted to the transmission chip system through the chip;
[0063] 4) The transmission chip system compares the detected data with the normal blood sugar concentration (3.1-6.9mmol / L) for judgment;
[0064] 5) If the client shows that the blood glucose concentration is within the normal range of human blood glucose (3.1-6.9mmol / L), the transmission chip will not issue a drug administration command to the biosensor, and the biosensor will not respond;
Embodiment 3
[0066] A design method for intelligent real-time drug administration to control hyperglycemia, including the following four steps:
[0067] 1) Enter the transmission chip and connect the device;
[0068] 2) In the blood glucose reference interface of the transmission chip, a normal blood glucose concentration range (3.1-6.9mmol / L) is set, and any blood glucose value within this range is considered normal;
[0069] 3) Receive the data from the biosensor at all times and compare it with the blood glucose reference (3.1-6.9mmol / L) of the transmission chip. If the blood glucose value is higher than 6.9mmol / L, the transmission chip will issue a command to the biosensor, and the biosensor will control the release of hypoglycemic drugs (such as insulin, metformin, etc.)
[0070] 4) The biosensor releases hypoglycemic drugs (such as insulin, metformin, etc.) to continue to regulate blood sugar, and the transmission chip receives data from the biosensor again. At this time, the blood ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com